Issue 2/2023
Content (27 Articles)
Erectile dysfunction and cirrhosis: prevalence and a potential therapy
David H. Van Thiel
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors
Jin Lei, Tao Yan, Linzhi Zhang, Bowen Chen, Jiamin Cheng, Xiaoqiang Gao, Zherui Liu, Yinyin Li, Shi Zuo, Yinying Lu
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Chen-Hua Liu, Cheng-Yuan Peng, Chun-Jen Liu, Chi-Yi Chen, Ching-Chu Lo, Kuo-Chih Tseng, Pei-Yuan Su, Wei-Yu Kao, Ming-Chang Tsai, Hung-Da Tung, Hao-Tsai Cheng, Fu-Jen Lee, Chia-Sheng Huang, Ke-Jhang Huang, Yu-Lueng Shih, Sheng-Shun Yang, Jo-Hsuan Wu, Hsueh-Chou Lai, Yu-Jen Fang, Po-Yueh Chen, Jow-Jyh Hwang, Chi-Wei Tseng, Wei-Wen Su, Chun-Chao Chang, Pei-Lun Lee, Jyh-Jou Chen, Chi-Yang Chang, Tsai‐Yuan Hsieh, Chung-Hsin Chang, Yi-Jie Huang, Jia-Horng Kao
Association of age at first birth and risk of non-alcoholic fatty liver disease in women: evidence from the NHANES
Huan-Huan Yang, Guo-Chong Chen, Meng-Ge Zhou, Li-Feng Xie, Yuan-Yuan Jin, Hao-Tian Chen, Ze-Kun Chen, Yu-Hao Kong, Chang-Zheng Yuan, Zhi-Hui Li
Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people
Xiaopeng Zhu, Qingxia Huang, Shuai Ma, Lingyan Chen, Qi Wu, Li Wu, Hui Ma, Xiaoming Li, Qian Li, Qiqige Aleteng, Yu Hu, Wanyuan He, Jian Gao, Huandong Lin, Huiru Tang, Xin Gao, Mingfeng Xia
Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, Wei Qiu, Wentao Mu, Kaiyuan Chai, Yannan Cao, Guangyi Wang, Guoyue Lv
Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis
Feng Gao, De-Chan Lu, Tian-Lei Zheng, Shi Geng, Jun-Cheng Sha, Ou-Yang Huang, Liang-Jie Tang, Pei-Wu Zhu, Yang-Yang Li, Li-Li Chen, Giovanni Targher, Christopher D. Byrne, Zu-Fang Huang, Ming-Hua Zheng
Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications
Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease
Ilaria Barchetta, Carla Lubrano, Flavia Agata Cimini, Sara Dule, Giulia Passarella, Arianna Dellanno, Alberto Di Biasio, Frida Leonetti, Gianfranco Silecchia, Andrea Lenzi, Maria Gisella Cavallo
Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study
Seung Mi Lee, Geum Joon Cho, Won Young Wi, Errol R. Norwitz, Bo Kyung Koo, Jeesun Lee, Young Mi Jung, Soo Heon Kwak, Chan-Wook Park, Jong Kwan Jun, Sae Kyung Joo, Min-Jeong Oh, Won Kim, Joong Shin Park
HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility
Xiaohan Cui, Xiao Yun, Meiling Sun, Renzhi Li, Xiajie Lyu, Yuanxiang Lao, Xihu Qin, Wenbin Yu
Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence
Huizhong Shi, Wenwen Zhang, Bingyang Hu, Yafei Wang, Ze Zhang, Ying Sun, Guankun Mao, Chonghui Li, Shichun Lu
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy
Wei Chen, Shuifang Hu, Zelong Liu, Yukun Sun, Jian Wu, Shunli Shen, Zhenwei Peng
Predictive power of portal pressure gradient remeasured shortly after transjugular intrahepatic portosystemic shunt
Li Ma, Jingqin Ma, Wen Zhang, Qingxin Liu, Zihan Zhang, Minjie Yang, Jiaze Yu, Xin Zhou, Shiyao Chen, Jian Wang, Jianjun Luo, Zhiping Yan
Distinct course of portal hypertension in patients with cirrhosis with gastric variceal bleeding as their first decompensation: a propensity score-matched study
Sanchit Sharma, Samagra Agarwal, Deepak Madhu, Randeep Rana, Anany Gupta, Srikanth Gopi, Deepak Gunjan, Anoop Saraya
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial
Rakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, Jaya Benjamin, Rakhi Maiwall, Ankur Jindal, Ashok Choudhary, Vijayaraghavan Rajan, Vinod Arora, Ankit Bhardwaj, Guresh Kumar, Manoj Kumar, Shiv K. Sarin
Prevalence and risk factors of erectile dysfunction in patients with liver cirrhosis: a systematic review and meta-analysis
Hye Jin Yoo, Bora Lee, Eun-Ae Jung, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Jiannan Qiu, Shasha Wu, Peng Wang, Yan Zhou, Zhongxia Wang, Yong Sun, Chunping Jiang
PIRO-CIC model can predict mortality and futility of care in critically ill cirrhosis patients in the intensive care unit
Rakhi Maiwall, Samba Siva Rao Pasupuleti, Harsh Vardhan Tevethia, Shiv Kumar Sarin
Comparison of the prognostic models for mortality in idiosyncratic drug-induced liver injury
Yan Wang, Cailun Zou, Aileen Wee, Jimin Liu, Zikun Ma, Tiantian Guo, Min Li, Yu Wang, Liwei Liu, Jidong Jia, Zhengsheng Zou, Xinyan Zhao
Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India
Shekhar Singh Jadaun, Rohit Mehtani, Ana Hasnain, Sushant Bhatia, Vikash Moond, Mukesh Kumar, Vikash Kuhad, Shweta Singh, Shaleen Agarwal, Subhash Gupta, Sanjiv Saigal
MAFLD: perceived stigma—a single-center Mexican patient survey
Nahum Méndez-Sánchez, Shreya C. Pal, Eduardo Fassio, Javier Díaz-Ferrer, Jorge Alberto Prado-Robles
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies
Chia-Yu Chiu, Krina Patel, Sheeba K. Thomas, Fareed Khawaja, Natalie J. M. Dailey Garnes, Hans C. Lee, Maro Ohanian, Ying Jiang, Lan S. Wang, Jessica P. Hwang, Harrys A. Torres
Developing real-world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond
Teh-Ia Huo, Jia-I Liao, Shu-Yein Ho
Reflections on prediction of microvascular invasion in hepatocellular carcinoma by pathology images
Wen-Tao Cai, Ning-Zhe Shen, Yang-Bin Lu, Jian-Qiang Huang, Zhi-Xuan Jiang, Xiao-Dong Chen
Correction to: HMGCL‑induced β‑hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4‑mediated ferroptosis susceptibility
Xiaohan Cui, Xiao Yun, Meiling Sun, Renzhi Li, Xiajie Lyu, Yuanxiang Lao, Xihu Qin, Wenbin Yu